20 Feb 2024

AstraZeneca completes Icosavax acquisition for $1.1bn

AstraZeneca has concluded the acquisition of the US-based clinical-stage biopharmaceutical company Icosavax in a $1.1bn deal. The latest development comes after the companies entered a definitive agreement to execute the…

16 Feb 2024

GSK concludes Aiolos Bio acquisition for $1.4bn

GSK has successfully concluded the acquisition of Aiolos Bio in a deal that could reach $1.4bn, marking a significant expansion of GSK's respiratory biologics portfolio. The agreement, signed last month,…

13 Feb 2024

AbbVie concludes acquisition of ImmunoGen for $10.1bn

AbbVie has completed the acquisition of ImmunoGen for $10.1bn, a move that significantly bolsters its oncology pipeline with promising treatments for solid tumours and haematologic malignancies. The companies signed a…

08 Feb 2024

Telix to acquire QSAM Biosciences for $123.1m

Australia-based global biopharmaceutical company Telix Pharmaceuticals has agreed to acquire US-based QSAM Biosciences for $123.1m. The deal comes after the companies signed a conditional non-binding term sheet for the prospective…

25 Jan 2024

Kyowa Kirin acquires Orchard Therapeutics for $477.6m

Kyowa Kirin, a Japan-based global speciality pharmaceutical company, has announced the successful completion of its acquisition of Orchard Therapeutics, a developer of hematopoietic stem cell gene therapies, for an equity…

[ajax_load_more post_type="post" taxonomy="category" taxonomy_terms="deals, deals-analysis, deal-news" taxonomy_operator="IN" images_loaded="true" posts_per_page="20" offset="7" pause="true" scroll="false" button_label="Load More Stories"]